Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F73ED18F.svg?ark=w1%2F20260515%2FF73ED18F)](https://nobleid.org/work/w1/20260515/F73ED18F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors